Amylin Pharmaceuticals Inc. (AMLN) said Monday that its diabetes drug Byetta doesn't share a connection to thyroid cancer risk seen in potential...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads